ClinConnect ClinConnect Logo
Search / Trial NCT06865404

Additive Regional Fascial Plain Blocks to Pectointercostal Fascial Block for Postoperative Pain Management After Cardiac Surgery: a Randomized Controlled Trial

Launched by ALEXANDRIA UNIVERSITY · Mar 4, 2025

Trial Information

Current as of June 27, 2025

Not yet recruiting

Keywords

Additive Regional Fascial Plain Blocks, Pectointercostal Fascial Block, Postoperative Pain Management After Cardiac Surgery

ClinConnect Summary

This clinical trial is studying how different types of pain relief techniques can help reduce postoperative pain for patients undergoing heart surgery. Specifically, researchers are looking at two methods: the Pectointercostal Fascial Block, which helps manage pain after surgery, and an additional technique called the Rectus Sheath Block or External Oblique Intercostal Plane Block, which may provide extra pain relief. This research is important because many patients experience severe pain after heart surgery, particularly in the area where the tube is inserted.

To participate in this trial, you need to be an adult between the ages of 18 and 60 who is scheduled for specific heart surgeries. However, some people may not be eligible, such as those with certain medical conditions, previous surgeries, or those taking chronic pain medications. If you decide to join the study, you’ll receive these pain relief treatments and help researchers understand which method works best for managing pain after heart surgery, ultimately aiming to improve your recovery experience.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The study will include adult patients of both sexes aged 18 to 60 who are scheduled to have fast-tracking elective on-pump cardiac surgery through a median sternotomy with epigastric drain insertion.
  • Exclusion Criteria:
  • patients who refused to participate in the study, also
  • who had Cognitive impairment or mental disorders,
  • Ages \<20 and \>65 years,
  • BMI \<18 and \>35,
  • patients with puncture site infection,
  • patients who documented allergy to local anesthetic drugs,
  • patients used to take chronic pain medications,
  • patients who made previous sternotomy or chest surgery and
  • patients with a history of substance abuse.

About Alexandria University

Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.

Locations

Alexandria, , Egypt

Patients applied

0 patients applied

Trial Officials

Islam Elbardan, Dr

Principal Investigator

University of Alexandria

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported